AnorMED stock to be listed on the Amex

By E. Janene Geiss

Philadelphia, Nov. 3 - AnorMED Inc. said the U.S. Securities and Exchange Commission declared the company's Form 40-F registration effective Thursday and the company will be listed on the American Stock Exchange.

AnorMED's stock will trade under the symbol AOM beginning Friday, Nov. 4, said a company news release.

"We believe that the listing of AnorMED's common shares on the Amex is a positive step towards increasing our presence internationally by allowing investors to trade our shares on a major U.S. exchange," Dr. Michael Abrams, chief executive officer and president, said in the release.

AnorMED is a chemistry-based biopharmaceutical company focused on discovery, development and commercialization of new therapeutic products in hematology, HIV and oncology.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.